FIELD: embryo implantation.
SUBSTANCE: group of inventions relates to the field of methods for preventing unsuccessful embryo implantation, as well as preventing or reducing the risk of developing ovarian hyperstimulation syndrome in a female subject suffering from polycystic ovary syndrome. A method is provided for preventing failed embryo implantation in a female subject suffering from polycystic ovary syndrome, comprising administering a composition containing myoinositol and D-chiroinositol in a mass ratio of 3.66:1, respectively, to this female subject. Also, the use of a composition containing myoinositol (MI) and D-chiroinositol (DCI) in a weight ratio of 3.66:1, respectively, in preventing or reducing the risk of developing ovarian hyperstimulation syndrome in a female subject suffering from polycystic ovary syndrome and undergoing a therapeutic procedure of ovarian stimulation is provided. The administration of a combination of MI/DCI at a weight ratio of 3.66:1 to women suffering from PCOS significantly increases the pregnancy rate due to the normalization of the implantation phase of the embryos, despite the high proportion of DCI relative to MI.
EFFECT: in addition, women with PCOS who have been treated with assisted reproductive technology have a lower risk of ovarian hyperstimulation when using a composition containing a combination of MI/DCI in the above ratio.
9 cl, 3 tbl, 1 ex, 1 dwg
Title | Year | Author | Number |
---|---|---|---|
APPLICATION OF TUNGSTEN (VI) SALTS FOR TREATMENT OF FEMALE INFERTILITY IN MAMMALS WITHOUT DIABETES | 2014 |
|
RU2635507C2 |
PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING POLYCYSTIC OVARY SYNDROME | 2020 |
|
RU2757220C1 |
TUNGSTEN (VI) SALTS USED TO TREAT INFERTILITY, FOR STIMULATING FERTILITY AND NORMAL REPRODUCTION IN A NON-DIABETIC FEMALE MAMMAL, AND FOR IMPROVING THE EFFECTIVENESS OF ASSISTED REPRODUCTION TECHNIQUES | 2014 |
|
RU2679623C2 |
DOUBLE NEUROKININ-1/NEUROKININ-3 RECEPTOR ANTAGONISTS FOR TREATING SEX HORMONE DEPENDENT DISEASES | 2016 |
|
RU2743206C2 |
METHODS OF TREATING INFERTILITY | 2016 |
|
RU2723098C2 |
COMPOSITION OF SUGARS WITH LOW GLYCEMIC INDEX | 2018 |
|
RU2813143C2 |
INTRAVAGINAL DEVICES CONTAINING PROGESTERONE | 2019 |
|
RU2830189C2 |
AGENT FOR TREATING FEMALE INFERTILITY AND INFERTILITY OF FEMALE ANIMALS | 2017 |
|
RU2740922C2 |
TREATMENT OR PREVENTION OF OVARY HYPERSTIMULATION SYNDROME (OHSS) WITH APPLICATION OF DOPHAMINE AGONIST | 2006 |
|
RU2416410C2 |
FERTILITY IMPROVING COMPOSITIONS | 2000 |
|
RU2246944C2 |
Authors
Dates
2023-02-28—Published
2018-04-19—Filed